SAN FRANCISCO, CA — Aug 2026 — NyquistAI, the AI-native intelligence platform purpose-built for medical device and biopharma regulatory, clinical, quality, and post-market surveillance teams, today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network.
The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. The program brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier AI models and products and turn them into measurable impact.
As an OpenAI Select Partner, NyquistAI will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into finished work.
"Becoming an OpenAI Select Partner validates what our customers experience every day: purpose-built AI, grounded in the right data and designed for the right domain, can fundamentally transform how life sciences teams work," said Michelle Wu, Co-founder and CEO of NyquistAI. "We're excited to continue our collaboration with OpenAI and bring even more advanced AI capabilities to regulatory, clinical, and quality teams around the world."
NyquistAI serves medical device and biopharma organizations globally with AI-powered regulatory strategy, clinical intelligence, quality automation, and post-market surveillance solutions. Its platform spans three core capability areas:
Regulatory Strategy Search
Search across FDA 510(k) clearances, guidance documents, global regulations, MAUDE adverse event reports, recalls, and clinical trial data to identify predicates, evaluate competitive landscapes, and develop regulatory strategies in minutes instead of weeks.
AI Workflows for MedTech
Accelerate regulatory and quality operations with AI-powered workflows, including global regulatory change monitoring, audit-ready document summarization, health authority communication preparation, and submission drafting powered by FDA, EU, MDSAP, and proprietary regulatory intelligence.
Fractional AI Services
Partner with NyquistAI to define an AI strategy, train teams, automate regulatory and quality workflows, and develop custom AI applications tailored to organizational needs.
Learn more about the OpenAI Partner Network: https://openai.com/business/partners/
Learn more about NyquistAI: https://www.nyquistai.com/
Explore the NyquistAI Plugin on ChatGPT: https://chatgpt.com/plugins/plugin_asdk_app_6944a6ce46408191b38807bc5444b5be